Yahoo
NYSE - Nasdaq Real Time Price USD

Molina Healthcare, Inc. (MOH)

204.78 +5.83 (+2.93%)
At close: 4:00:02 PM EDT
204.50 -0.28 (-0.14%)
After hours: 6:13:46 PM EDT
Trade MOH on Coinbase
Chart Range Bar
Loading chart for MOH

What's happening with MOH?

21m ago
Powered by Yahoo Scout

Molina Healthcare’s third-quarter results showed an earnings beat, but thin margins and elevated medical costs remain central concerns. Management reaffirmed 2026 adjusted EPS guidance of at least $5.25and described Medicaid margins as near a cyclical trough, while new contracts could support stronger earnings from 2027.

Powered by Yahoo Scout
  • Previous Close 198.95
  • Open 201.64
  • Bid 204.40 x 20000
  • Ask 204.47 x 20000
  • Day's Range 198.34 - 206.43
  • 52 Week Range 121.06 - 244.89
  • Volume 1,752,750
  • Avg. Volume 684,493
  • Market Cap (intraday) 10.649B
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) --
  • EPS (TTM) -0.68
  • Earnings Date Oct 21, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 219.53
  • Morningstar Rating Rating available with Stock Picks access

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.

www.molinahealthcare.com

19,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MOH
18.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

MOH
35.53%
S&P 500 (^GSPC)
11.11%

3-Year Return

MOH
37.56%
S&P 500 (^GSPC)
81.91%

5-Year Return

MOH
30.75%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 11.08B
Earnings 38M
Profit Margin 0.34%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
2B
4B
6B
8B
10B
-1.0%
-0.5%
0.0%
0.5%

Analyst Insights

View More

Analyst Price Targets

163.00 Low
219.53 Average
204.78 Current
266.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/27/2026
Analyst JP Morgan
Rating Action Maintains
Rating Neutral
Price Action Raises
Price Target 220 -> 225

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.11%

  • Return on Assets (ttm)

    1.07%

  • Return on Equity (ttm)

    -1.15%

  • Revenue (ttm)

    42.08B

  • Net Income Avi to Common (ttm)

    -48M

  • Diluted EPS (ttm)

    -0.68

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.58B

  • Total Debt/Equity (mrq)

    95.07%

  • Levered Free Cash Flow (ttm)

    416.38M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: